|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 175,200.00 KRW | +1.21% |
|
-4.58% | +1.64% |
| 07-07 | Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA | MT |
| 07-03 | South Korean Shares Jump on Bargain-Hunting, Chip Stock Gains | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CELLTRION, INC. | Other Biotechnology & Medical Research | +1.21% | -4.58% | +1.64% | +3.00% | -18.82% | 26.76B |  |  | |
- Stock Market
- Stocks
- A068270 Stock
- Charts Celltrion, Inc.
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
